Webinar

Getting pharma deals right: Assessing the true commercial potential of biopharma assets

TSPE LS Webinar

Pharma deal value is only as strong as the forecast behind it. Data shows that nearly 60% of pharmaceutical sales forecasts miss by a factor of two or more, often due to avoidable commercial assumptions.

Our upcoming webinar examines the most common and financially impactful mistakes in pharmaceutical sales forecasting and shares how to build a forecast that truly reflects market reality. 

In this webinar, we will explore:

  • Why overreliance on US-only extrapolations and one-size-fits-all global assumptions creates valuation distortions across therapeutic areas and regions.
  • Why unrealistic pricing assumptions are a primary source of forecast error and how proper net price modeling, including gross-to-net effects and 340B discounting, fundamentally changes valuation outcomes. 
  • How to robustly determine preference shares and calibrate physician responses to reflect real-world behavior. 
  • The critical role of payer management tools in shaping prescription volumes across major markets. 
  • How to translate preference into market share by integrating price, uptake, competition, and access dynamics. 

This webinar is free of charge. Register now and explore expert insights to strengthen your next deal decision. 

Event details:
Tuesday, May 6
04:00 – 05:00 p.m. CEST; 10:00 – 11:00 a.m. EDT

Event details
  • Webinar
  • Getting pharma deals right: Assessing the true commercial potential of biopharma assets
  • Wed, May 6, 2026
  • 16:00 - 17:00 CEST |
    10:00 - 11:00 EDT

Speakers

Partner
Boston, USA
Partner
Zurich, Switzerland
Director
Zurich, Switzerland

Contact

Looking for more information or questions about the event?